Description: Cosmos Holdings Inc. operates as a vertically integrated pharmaceutical company. It offers proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications, and medical devices with EU distribution network. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes and has a network of clients in Germany, the United Kingdom, the United Arab Emirates, Denmark, Italy, France, Singapore, Ireland, Sweden, Poland, the Netherlands, and Greece, as well as has distribution centers in Thessaloniki, Greece, Athens, Greece and Harlow, the United Kingdom. The company was formerly known as Prime Estates and Developments, Inc. and changed its name to Cosmos Holdings Inc. in November 2013. Cosmos Holdings Inc. was incorporated in 2009 and is based in Chicago, Illinois.
Home Page: www.cosmosholdingsinc.com
COSM Technical Analysis
141 West Jackson Boulevard
Chicago,
IL
60604
United States
Phone:
312 536 3102
Officers
| Name | Title |
|---|---|
| Mr. Grigorios Siokas | Chairman & CEO |
| Mr. Georgios Terzis | Chief Financial Officer |
| Mr. Pavlos Ignatiades | Chief Operating Officer |
| Mr. Demetrios G. Demetriades | Sec. & Independent Director |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Providers & Services |
| GIC Sub-Industry: | Health Care Distributors |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 16.6173 |
| Price-to-Sales TTM: | 1.0834 |
| IPO Date: | 2012-10-11 |
| Fiscal Year End: | December |
| Full Time Employees: | 95 |